EANM’14 – CTE Session I
October 19, 2014, 08:15 – 09:45
Advances in Nuclear Cardiology
Chairperson: H. Ryder (Dublin)
- To give an overview of the present state of nuclear myocardial imaging and its usefulness in clinical cardiology
- To compare the effective role of nuclear myocardial imaging with other non-nuclear medicine diagnostic tools
- To speculate on future developments in the field of nuclear cardiology radiopharmaceuticals
- To review the challenges faced by technologists in performing and analysing nuclear cardiology examinations using both SPECT-CT and PET-CT technologies
Nuclear myocardial imaging is a field which has developed exponentially with the introduction of both SPECT-CT and PET-CT technologies. In recent years the introduction of CT cardiac angiography and MRI cardiac angiography have revolutionised those modalities in the field clinical cardiology, reducing the burden on the highly expensive cardiac catherisation angiography technique, with its associated morbidity rates. However, none of the above techniques have been able to replicate the ability of nuclear cardiology to delineate the physiological changes experienced by cardiac muscle tissue and quantify the viability of the tissue in replicable examinations. Furthermore, extensive work is being carried out on dose optimisation and dose reduction in this field, which further enhances the desirability of the availability of nuclear cardiology in clinical cardiac centres.
The improved hardware for both SPECT-CT and PET-CT, new software and advanced image reconstruction techniques; and advances in development of new myocardial radiopharmaceuticals mean that the field of nuclear cardiology is still a vibrant and vital area of clinical cardiac management. This session, in conjunction with the launch of the 2014 EANM Technologist’s Guide, will expand upon the opportunities present in the nuclear cardiology field today, and in years to come.
Nuclear Cardiology, Radiopharmaceuticals, Advances, SPECT-CT, PET-CT, Imaging Techniques